Carrying on CombiMatrix's Chip Business, CustomArray Sets Sights on Sequence-Capture Market

CEO Brooke Anderson said that the firm believes its sequence-capture approach will be more flexible and more affordable than offerings by established players in the target enrichment market, like Agilent, Roche NimbleGen, and RainDance.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories